MAS
IDXX icon

Meeder Advisory Services’s Idexx Laboratories IDXX Stock Holding History

Meeder Advisory Services’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$840K Sell
1,596
-300
-16% -$168K 0.03% 327
2026
Q1 		$1.07M Buy
1,896
+25
+1% +$16K 0.04% 265
2025
Q4 		$1.27M Buy
1,871
+102
+6% +$69.5K 0.05% 231
2025
Q3 		$1.13M Buy
1,769
+244
+16% +$148K 0.05% 244
2025
Q2 		$818K Buy
1,525
+42
+3% +$20.1K 0.04% 293
2025
Q1 		$623K Sell
1,483
-89
-6% -$38.6K 0.04% 317
2024
Q4 		$650K Sell
1,572
-377
-19% -$165K 0.04% 302
2024
Q3 		$985K Sell
1,949
-180
-8% -$87.4K 0.06% 243
2024
Q2 		$1.04M Buy
2,129
+540
+34% +$271K 0.07% 216
2024
Q1 		$858K Buy
1,589
+66
+4% +$36.1K 0.09% 198
2023
Q4 		$845K Buy
1,523
+38
+3% +$17.8K 0.1% 182
2023
Q3 		$649K Sell
1,485
-222
-13% -$111K 0.08% 211
2023
Q2 		$857K Sell
1,707
-3
-0.2% -$1.44K 0.09% 190
2023
Q1 		$855K Buy
1,710
+219
+15% +$105K 0.1% 178
2022
Q4 		$608K Buy
+1,491
New +$579K 0.08% 234

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Meeder Advisory Services's IDXX Position: Q2 2026 in Review

Meeder Advisory Services reduced its Idexx Laboratories (IDXX) stake by 16% in Q2 2026, selling an estimated $168K and leaving 1,596 shares worth $840K. The position accounts for 0.03% of the portfolio, ranked #327.

Meeder Advisory Services first reported a position in IDXX in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.27M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Meeder Advisory Services held 1,596 shares of Idexx Laboratories worth $840K as of Q2 2026.
  • Meeder Advisory Services sold 300 Idexx Laboratories shares in Q2 2026, an estimated $168K.
  • Idexx Laboratories made up 0.03% of Meeder Advisory Services's portfolio in Q2 2026, its #327 holding.
  • Meeder Advisory Services first reported a position in Idexx Laboratories in Q4 2022 and has held it in 15 quarters since.
  • Meeder Advisory Services's Idexx Laboratories position peaked at $1.27M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.